| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/17/2006 | CA2595526A1 Colonic delivery of active agents |
| 08/17/2006 | CA2594434A1 Controlled release compositions based on block copolymers |
| 08/17/2006 | CA2594408A1 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 08/17/2006 | CA2592776A1 Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
| 08/16/2006 | EP1690876A1 Nonreducing beta-glucan derivative |
| 08/16/2006 | EP1690551A2 Method of purifying a surfactant by ultrafiltration |
| 08/16/2006 | EP1690547A1 Prevention and treatment of amyloidogenic disease |
| 08/16/2006 | EP1690544A2 Pharmaceutical composition containing decoy and method of using the same |
| 08/16/2006 | EP1690539A2 Salts of tiotropium for treating inflammatory disorders |
| 08/16/2006 | EP1690522A1 Cosmetic nanoemulsion comprising hydroxylated urea compound |
| 08/16/2006 | EP1689864A2 Method and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions |
| 08/16/2006 | EP1689846A2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 08/16/2006 | EP1689789A2 Novel cyclodextrin dimers and derivatives thereof, methods for preparing them and their use, in particular, for solubilizing pharmacologically active substances |
| 08/16/2006 | EP1689787A2 Cellulose interpolymers and method of oxidation |
| 08/16/2006 | EP1689783A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 08/16/2006 | EP1689778A1 Rgd targeting moiety its porduction and use |
| 08/16/2006 | EP1689444A1 Dna delivery with gemini cationic surfactants |
| 08/16/2006 | EP1689443A2 Polymalic acid-based multifunctional drug delivery system |
| 08/16/2006 | EP1689442A2 Composition comprising antibodies and methods of using the same for targeted nanoparticulate active agent delivery |
| 08/16/2006 | EP1689441A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 08/16/2006 | EP1689440A2 Use of lipopeptides for activating t lymphocytes through the skin |
| 08/16/2006 | EP1689439A2 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 08/16/2006 | EP1689438A1 A delivery system for active components as part of an endible composition having preselected tensile strength |
| 08/16/2006 | EP1689437A1 Erythropoietin solution formulation |
| 08/16/2006 | EP1689434A1 The use of anti biotics as vaccine adjuvants |
| 08/16/2006 | EP1689428A2 Minimization of drug oxidation in drug irradiated excipients formulations |
| 08/16/2006 | EP1689426A1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 08/16/2006 | EP1689425A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689388A1 Association of antimicrobial compounds with surfaces and polymers |
| 08/16/2006 | EP1689366A1 Macrogol preparation |
| 08/16/2006 | EP1689365A1 Drug delivery vehicles and uses thereof |
| 08/16/2006 | EP1654003A4 Preventative effects of morinda citrifolia on mammary breast cancer |
| 08/16/2006 | EP1575618B1 Dispersible pharmaceutical compositions |
| 08/16/2006 | EP1517722B1 Method of coating transdermal drug delivery devices having coated microprotrusions |
| 08/16/2006 | EP1478352B1 Pharmaceutical dosage form and method for the production thereof |
| 08/16/2006 | EP1469827A4 Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| 08/16/2006 | EP1467707B1 Composition for easing human childbirth |
| 08/16/2006 | EP1296647B1 Polymeric micelle compositions |
| 08/16/2006 | EP1294920B1 Deesterified pectins, processes for producing such pectins, and stabilized acidic liquid systems comprising the same |
| 08/16/2006 | EP1276471B1 Membrane delivery system |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1252192B1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2006 | EP1220670B1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 08/16/2006 | EP1123120B1 Medicinal aerosol formulation |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1820024A Novel poly(ethylene glycol) modified compounds and uses thereof |
| 08/16/2006 | CN1819863A Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product |
| 08/16/2006 | CN1819847A Vitronectin receptor antagonist compounds and their use in the preparation of diopharmaceuticals |
| 08/16/2006 | CN1819846A Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819828A Nasal pharmaceutical composition of piribedil |
| 08/16/2006 | CN1819825A Amino acid iodine composition, its production and use thereof |
| 08/16/2006 | CN1819817A The solid dispersion of tacrolimus |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817362A Chinese medicinal composition for treating heart failure and oral preparation |
| 08/16/2006 | CN1817340A Composition of sodium fusidafe as injection and preparing method thereof |
| 08/16/2006 | CN1269909C Method for preparing elastomer based on silioxane |
| 08/16/2006 | CN1269879C Improved solid media |
| 08/16/2006 | CN1269870C Lactic acid polymer and process for producing the same |
| 08/16/2006 | CN1269531C Light-stabilized in vivo stain composition and method of manufacture |
| 08/16/2006 | CN1269530C Antibody-dye conjugates for binding to target structures of angiogenesis in order to introperatively depict tumor peripheries |
| 08/16/2006 | CN1269473C Cell necrosis signal identifying type intelligent adminisration carrier |
| 08/16/2006 | CN1269472C Method for preparing ten nanometers level solid lipid nanometer particle |
| 08/16/2006 | CN1269470C Method for producing powdery formulations |
| 08/16/2006 | CN1269420C Use of nutritional compositions which contain non-digestible polysaccharides |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091336 Lentinan is dissolved in alkali solution, then acid solution is added to neutralize the pH, mixing with lyophilized excipient, filtered to eliminate bacteria, subpackaged into an ampoule or bottle, sealed after lyophilization and dried to obtain the final product |
| 08/15/2006 | US7091325 Fibrin/fibrinogen-binding conjugate |
| 08/15/2006 | US7091321 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/15/2006 | US7091193 A freeze drying mixture comprising an epothilone and a cyclodextrin; antiproliferative agent, anticarcinogenic agent; cancer, psoriasis, restenosis, multiple sclerosis, rheumatoid arthritis, atherosclerosis; side effect reduction |
| 08/15/2006 | US7091192 Linear cyclodextrin copolymers |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091186 p-Amidobenzylethers in drug delivery agents |
| 08/15/2006 | US7091175 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091028 Method for directed packaging of molecular substances in protein shells |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090870 Dry power inhaler excipient, process for its preparation and pharmaceutical compositions containing it |
| 08/15/2006 | US7090867 Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090863 Hypocholesterolemic composition and methods of use |
| 08/15/2006 | US7090862 Administering natural tocopherols including alpha- and gamma-forms; also prenatal supplements and supplements for lactating women |
| 08/15/2006 | US7090859 Ketoprofen compositions and methods of making them |
| 08/15/2006 | US7090846 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 08/15/2006 | US7090844 monoclonal antibody comprising a heavy chain amino acid; treatment of disorders associated with increased activity of MUC18, in particular, tumors, such as melanomas. |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | US7090832 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same |
| 08/15/2006 | US7090831 Pharmaceutical aerosol formulation |
| 08/15/2006 | US7090691 Photodynamic therapy for the treatment of hair loss |
| 08/15/2006 | US7089934 Delivery of oral drugs |
| 08/15/2006 | CA2395231C Hydrogel-driven layered drug dosage form |
| 08/15/2006 | CA2287267C Improved methods for processing activated protein c |
| 08/15/2006 | CA2266622C Hyaluronic drug delivery system |
| 08/15/2006 | CA2263102C Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 08/15/2006 | CA2164776C Pharmaceutical, orally applicable composition |
| 08/10/2006 | WO2006084211A2 Thermoplastic articles containing a medicament |
| 08/10/2006 | WO2006084141A2 Suspension formulation of interferon |
| 08/10/2006 | WO2006084089A2 Process for the preparation of polymer conjugates |